Senior scientific and technical executive with more than three decades of leadership across computational biology, molecular neurobiology, pharmacogenomics, AI-enabled medical technology, translational medicine, medical simulation, and healthcare innovation. Career contributions include foundational Alzheimer’s disease molecular biology, early regulated machine-learning medical imaging, FDA-reviewed diagnostic technology, pharmacogenomic clinical decision support, electronic health-record innovation, and AI-first precision-medicine platforms.
-126 peer-reviewed publications, H-index of 41
-13 published patents
Product development:
• GeneSight® psychotropic pharmacogenomic diagnostic test; acquired by Myriad Genetics.
• GenomeQuest® sequence patent search engine; acquired by Monsanto.
• Azyxxi electronic health record; acquired by Microsoft Health Solutions.
• Virtual I.V. simulation system with haptics and 3D graphics; acquired by Laerdal Medical Corporation.
• Roche AutoCyte Pap-smear imaging using convolutional neural networks; acquired by Becton Dickinson.
Senior scientific and technical executive with more than three decades of leadership across computational biology, molecular neurobiology, pharmacogenomics, AI-enabled medical technology, translational medicine, medical simulation, and healthcare innovation. Career contributions include foundational Alzheimer’s disease molecular biology, early regulated machine-learning medical imaging, FDA-reviewed diagnostic technology, pharmacogenomic clinical decision support, electronic health-record innovation, and AI-first precision-medicine platforms.
-126 peer-reviewed publications, H-index of 41
-13 published patents
Product development:
• GeneSight® psychotropic pharmacogenomic diagnostic test; acquired by Myriad Genetics.
• GenomeQuest® sequence patent search engine; acquired by Monsanto.
• Azyxxi electronic health record; acquired by Microsoft Health Solutions.
• Virtual I.V. simulation system with haptics and 3D graphics; acquired by Laerdal Medical Corporation.
• Roche AutoCyte Pap-smear imaging using convolutional neural networks; acquired by Becton Dickinson.